文献速递心脑血管急症消化、代谢与肾脏急症

年龄校正D-二聚体截断值用于排除深静脉血栓

Age-Adjusted D-Dimer Cutoff Levels to Rule Out Deep Vein Thrombosis.
PubMed 文献 · JAMA · 2026-01-01
一句话结论在疑似下肢DVT的急诊门诊患者中,采用年龄校正D-二聚体截断值(≥50岁者年龄×10 µg/L)可安全排除DVT,且使更多患者免于影像学检查。

该多国、多中心前瞻性管理结局研究在比利时、加拿大、法国和瑞士27个中心纳入3205例急诊疑似DVT门诊患者,采用Wells评分评估临床验前概率、高敏D-二聚体检测及下肢加压超声的序贯诊断策略,排除DVT者随访3个月。在2169例非高风险或不 Likely 临床概率患者中,531例(24.5%)D-二聚体<500 µg/L,另有161例(7.4%)D-二聚体在500 µg/L至年龄校正截断值之间,后者随访期无静脉血栓栓塞事件失败(0%,95%CI 0%-2.3%)。≥75岁患者中,采用年龄校正截断值使D-二聚体阴性比例从33/379(8.7%)提高至99/379(26.1%),无假阴性结果。作者认为年龄校正D-二聚体截断值可能安全排除DVT。

要点

  • ≥50岁疑似DVT患者,年龄校正D-二聚体截断值为年龄×10 µg/L,用于非高风险或不 Likely 临床概率者。
  • D-二聚体在500 µg/L至年龄校正截断值之间的患者,3个月随访症状性静脉血栓栓塞事件失败率为0%(95%CI 0%-2.3%)。
  • ≥75岁患者采用年龄校正截断值后D-二聚体阴性比例从8.7%(33/379)升至26.1%(99/379),无假阴性。
  • 在2169例非高风险或不 Likely 临床概率患者中,531例(24.5%)D-二聚体<500 µg/L,161例(7.4%)位于500 µg/L与年龄校正截断值之间。

适用人群与场景

  • 急诊科就诊的疑似下肢深静脉血栓门诊患者。
  • 纳入年龄≥50岁患者以应用年龄校正D-二聚体截断值;研究纳入总人群年龄中位数59岁,女性1737例(54%)。

诊断标准与关键阈值

  • 采用Wells评分评估临床验前概率,分为非高风险或不 Likely 与高风险或 Likely。
  • 年龄校正D-二聚体截断值:≥50岁患者为年龄×10 µg/L。
  • 传统D-二聚体截断值为500 µg/L。
  • DVT患病率为14%。

处置流程与药物剂量

  • 第一步:用Wells评分评估临床验前概率。
  • 第二步:对非高风险或不 Likely 临床概率患者检测高敏D-二聚体;D-二聚体<500 µg/L可排除DVT;D-二聚体在500 µg/L至年龄校正截断值之间亦可排除DVT。
  • 第三步:对D-二聚体≥年龄校正截断值或高风险/Likely患者行下肢加压超声。
  • 第四步:排除DVT者随访3个月,观察症状性静脉血栓栓塞事件。

研究设计与关键结果

  • 多国、多中心前瞻性管理结局研究,27个中心,纳入3205例急诊疑似DVT门诊患者,DVT患病率14%。
  • 2169例非高风险或不 Likely 临床概率患者中,531例(24.5%,95%CI 22.7%-26.4%)D-二聚体<500 µg/L;161例(7.4%,95%CI 6.4%-8.6%)D-二聚体在500 µg/L至年龄校正截断值之间。
  • D-二聚体≥500 µg/L但低于年龄校正截断值的患者随访期无失败,失败率0%(95%CI 0%-2.3%)。
  • ≥75岁患者中,采用年龄校正截断值较500 µg/L截断值使D-二聚体阴性比例从33/379(8.7%,95%CI 6.3%-12.0%)提高至99/379(26.1%,95%CI 22.0%-30.8%),无假阴性。

证据类型、等级与局限

  • 证据类型:多国、多中心前瞻性管理结局研究。
  • 作者结论:年龄校正D-二聚体截断值可能安全排除DVT,并与更多患者可有效排除DVT相关。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对急诊疑似DVT且Wells评分为非高风险或不 Likely 的≥50岁患者,D-二聚体在500 µg/L至年龄×10 µg/L之间时,可依据本策略排除DVT而不行加压超声。
  • 对≥75岁患者,采用年龄校正截断值可使更多患者免于影像学检查,且本研究中无假阴性。

指南或共识出处

  • 临床试验注册号:ClinicalTrials.gov NCT02384135。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

IMPORTANCE: The age-adjusted D-dimer cutoff (age × 10 µg/L in patients 50 years or older), safely increases the diagnostic yield of D-dimer in patients with suspected pulmonary embolism but has not been validated in patients with suspected leg deep vein thrombosis (DVT).

OBJECTIVE: To prospectively validate whether using an age-adjusted D-dimer cutoff allows clinicians to safely rule out DVT.

DESIGN, SETTING, AND PATIENTS: Multicenter, multinational prospective management outcome study conducted in 27 centers in Belgium, Canada, France, and Switzerland between January 2015 and October 2022 (last follow-up visit, January 30, 2023) and including outpatients presenting to the emergency department with suspected DVT.

INTERVENTIONS: Patients were assessed by a sequential diagnostic strategy based on the assessment of clinical pretest probability by the Wells score, a highly sensitive D-dimer test, and leg compression ultrasonography. Patients in whom DVT was ruled out were followed up for a 3-month period.

MAIN OUTCOME AND MEASURE: The primary outcome was the rate of adjudicated symptomatic venous thromboembolic events during follow-up in patients in whom DVT was ruled out based on a D-dimer value between the conventional cutoff of 500 µg/L and their age-adjusted cutoff.

RESULTS: A total of 3205 patients were included. Median age was 59 years, and 1737 (54%) were female. DVT prevalence was 14%. Among the 2169 patients with a non-high or unlikely clinical probability, 531 (24.5% [95% CI, 22.7%-26.4%]) had a D-dimer level less than 500 µg/L, and 161 additional patients (7.4% [95% CI, 6.4%-8.6%]) had a D-dimer level between 500 µg/L and their age-adjusted cutoff. No failures were identified in patients with a D-dimer level 500 µg/L or greater but below the age-adjusted cutoff (0% [95% CI, 0%-2.3%]). Among patients 75 years or older, using the age-adjusted cutoff instead of the 500-µg/L cutoff increased the proportion of negative D-dimer from 33 of 379 (8.7% [95% CI, 6.3%-12.0%]) to 99 of 379 (26.1% [95% CI, 22.0%-30.8%]), without any false-negative test results.

CONCLUSIONS AND RELEVANCE: The age-adjusted D-dimer cutoff may safely rule out DVT and was associated with a larger number of patients in whom DVT could be effectively ruled out.

TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02384135.

来源:JAMA,查看原文。版权归原作者所有。

参考来源

  1. Le Gal G, Robert-Ebadi H, Thiruganasambandamoorthy V, et al. Age-Adjusted D-Dimer Cutoff Levels to Rule Out Deep Vein Thrombosis. JAMA. 2026. PMID: 41490105. doi:10.1001/jama.2025.21561

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。